Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019025934) A STABLE ORAL PHARMACEUTICAL COMPOSITION OF PIMAVANSERIN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/025934 International Application No.: PCT/IB2018/055667
Publication Date: 07.02.2019 International Filing Date: 30.07.2018
IPC:
A61K 31/395 (2006.01) ,A61K 31/44 (2006.01) ,A61K 31/4409 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4409
only substituted in position 4, e.g. isoniazid, iproniazid
Applicants:
KASHIV PHARMA LLC [US/US]; 995 Route 202/206, Bridgewater, New Jersey Bridgewater, New Jersey 08807, US
Inventors:
PATEL, Jitendra Shantilal; IN
PATEL, Suhag Mayankkumar; IN
BHATT, Nehal Mayur; IN
DHULIA, Dhaval Mukeshbhai; IN
PUROHIT, Parva Yogeshchandra; IN
Priority Data:
20172102749502.08.2017IN
Title (EN) A STABLE ORAL PHARMACEUTICAL COMPOSITION OF PIMAVANSERIN
(FR) COMPOSITION PHARMACEUTIQUE ORALE STABLE DE PIMAVANSÉRINE
Abstract:
(EN) The present invention relates to a stable orally disintegrating pharmaceutical formulation comprising pimavanserin or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention further relates to a stable dispersible pharmaceutical formulation comprising pimavanserin or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients. Moreover, the present invention also relates to a novel pharmaceutical sachet formulation comprising an effective amount of pimavanserin or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients.
(FR) La présente invention concerne une formulation pharmaceutique stable se délitant oralement comprenant de la pimavansérine ou un sel pharmaceutiquement acceptable de celle-ci et un ou plusieurs excipients pharmaceutiquement acceptables. La présente invention concerne en outre une composition pharmaceutique dispersible stable comprenant de la pimavansérine ou un sel pharmaceutiquement acceptable de celle-ci et un ou plusieurs excipients pharmaceutiquement acceptables. De plus, la présente invention concerne également un nouvelle formulation pharmaceutique en sachet comprenant une quantité efficace de pimavansérine ou d'un sel pharmaceutiquement acceptable de celle-ci et un ou plusieurs excipients pharmaceutiquement acceptables.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Licensing availability request The applicant has requested the International Bureau to indicate the availability for licensing purposes of the invention(s) claimed in this international application